{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:14:51Z","timestamp":1790936091823,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":5083,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1046\/j.0022-202x.2001.01642.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T06:00:38Z","timestamp":1047448838000},"page":"155-163","source":"Crossref","is-referenced-by-count":95,"title":["Promoter Polymorphisms of the Genes Encoding Tumor Necrosis Factor-\u03b1 and Interleukin-1\u03b2 are Associated with Different Subtypes of Psoriasis Characterized by Early and Late Disease Onset"],"prefix":"10.1016","volume":"118","author":[{"given":"Kristian","family":"Reich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rotraut","family":"M\u00f6ssner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inke R.","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6tz","family":"Westphal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0010","first-page":"118","article-title":"Tumor necrosis factor-alpha gene polymorphism in psoriasis","volume":"14","author":"Arias","year":"1997","journal-title":"Exp Clin Immunogenet"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0015","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1172\/JCI1476","article-title":"IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach","volume":"101","author":"Asadullah","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0020","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.0022-202x.2001.01317.x","article-title":"Effects of systemic interleukin-10 therapy on psoriatic skin lesions: histologic, immunohistologic, and molecular biology findings","volume":"116","author":"Asadullah","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0025","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1046\/j.1523-1747.1999.00749.x","volume":"113","author":"Austin","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/sj.gene.6363645","article-title":"Cytokine gene polymorphism in human disease: on-line databases","volume":"1","author":"Bidwell","year":"1999","journal-title":"Genes Immun"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0035","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/1523-1747.ep12494196","article-title":"Interleukin-1 receptor antagonist production by human keratinocytes","volume":"98","author":"Bigler","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0040","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2249.1995.tb03793.x","article-title":"Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease","volume":"102","author":"Bioque","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0045","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2230.1994.tb02687.x","article-title":"Correlated increases of tumour necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients\u2014relationships with disease severity","volume":"19","author":"Bonifati","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0050","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0167-5699(98)01381-4","article-title":"The pathogenesis of psoriasis: immunological facts and speculations","volume":"20","author":"Bos","year":"1999","journal-title":"Immunol Today"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0055","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1084\/jem.182.5.1259","article-title":"Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis","volume":"182","author":"Cabrera","year":"1995","journal-title":"J Exp Med"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0060","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1006\/mgme.2000.3031","article-title":"Advances in the search for psoriasis susceptibility genes","volume":"71","author":"Capon","year":"2000","journal-title":"Mol Genet Metab"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0065","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8<1489::AID-CNCR17>3.0.CO;2-1","article-title":"Polymorphism in the tumor necrosis factor alpha promoter region and in the heat shock protein 70 genes are associated with malignant tumors","volume":"80","author":"Couchane","year":"1997","journal-title":"Cancer"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0070","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00188619","article-title":"A polymorphic variation in a putative regulation box of the TNFA promoter region","volume":"39","author":"D'Alfonso","year":"1994","journal-title":"Immunogenetics"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0075","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2249.1995.tb05549.x","article-title":"Cytokine production by normal human monocytes. inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism","volume":"99","author":"Danis","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0080","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s001250050926","article-title":"Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance","volume":"41","author":"Day","year":"1998","journal-title":"Diabetologia"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0085","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/eji.1830250623","article-title":"Enhanced production of biologically active interleukin-1 alpha and interleukin-1 beta by psoriatic epidermal cells ex vivo: evidence of increased cytosolic interleukin-1 beta levels and facilitated interleukin-1 release","volume":"25","author":"Debets","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0090","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.4049\/jimmunol.158.6.2955","article-title":"The IL-1 system in psoriatic skin. IL-1 antagonist sphere of influence in lesional psoriatic epidermis","volume":"158","author":"Debets","year":"1997","journal-title":"J Immunol"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0095","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1056\/NEJM200009073431011","article-title":"The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1","volume":"343","author":"Dinarello","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0100","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/35006081","article-title":"Interleukin-1 polymorphisms associated with increased risk of gastric cancer","volume":"404","author":"El-Omar","year":"2000","journal-title":"Nature"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2340\/0001555577273276","article-title":"Evidence that HLA-Cw6 determines early onset of psoriasis, obtained using sequence-specific primers (PCR-SSP)","volume":"77","author":"Enerback","year":"1997","journal-title":"Acta Derm Venereol"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0110","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1089\/jir.1995.15.887","article-title":"Characterization of protein complexes formed on the repressor elements of the human tumor necrosis factor alpha gene","volume":"15","author":"Fong","year":"1995","journal-title":"J Interferon Cytokine Res"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0115","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/hmg\/1.6.450","article-title":"Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta)","volume":"1","author":"di Giovine","year":"1992","journal-title":"Hum Mol Genet"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0120","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0014-5793(91)81360-K","article-title":"Interleukin 1 receptor antagonist in human epidermis and cultured keratinocytes","volume":"294","author":"Gruaz-Chatellard","year":"1991","journal-title":"FEBS Lett"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0125","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1365-2362.1998.00277.x","article-title":"Inflammatory bowel disease: no association between allele combinations of the (IL) 1\u03b2 and IL-1 receptor antagonist gene polymorphisms","volume":"28","author":"Hacker","year":"1998","journal-title":"Eur J Clin Invest"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0130","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s004030050338","article-title":"Genetics of psoriasis","volume":"290","author":"Henseler","year":"1998","journal-title":"Arch Dermatol Res"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0135","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0190-9622(85)70188-0","article-title":"Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris","volume":"13","author":"Henseler","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0140","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/1523-1747.ep12337469","article-title":"A TNF-alfa promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis","volume":"109","author":"Hohler","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0145","first-page":"65","article-title":"A simple sequentially rejective multiple test procedure","volume":"6","author":"Holm","year":"1979","journal-title":"Scand J Stat"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0150","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2598::AID-IMMU2598>3.0.CO;2-K","article-title":"IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1\u03b2 genes","volume":"28","author":"Hurme","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0155","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1523-1747.1999.00541.x","article-title":"Promoter polymorphism at -238 of the tumor necrosis factor alpha gene is not associated with early onset psoriasis when tested by the transmission disequilibrium test","volume":"112","author":"Jacob","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0160","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1086\/301899","article-title":"Linkage analysis of human leukocyte antigen (HLA) markers in familial psoriasis: strong disequilibrium effects provide evidence for a major determinant in the HLA-B\/-C region","volume":"63","author":"Jenisch","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0165","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1034\/j.1399-0039.1999.530203.x","article-title":"Linkage disequilibrium analysis of familial psoriasis: identification of multiple disease-associated MHC haplotypes","volume":"53","author":"Jenisch","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0170","first-page":"47","article-title":"The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1 beta production in human monocytes and neutrophils","volume":"13","author":"Jenkins","year":"1994","journal-title":"Lymphokine Cytokine Res"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0175","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1046\/j.1523-1747.2000.00001.x","article-title":"Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-\u03b1 238A promoter polymorphism","volume":"114","author":"Kaluza","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0180","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/9649","article-title":"A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria","volume":"22","author":"Knight","year":"1999","journal-title":"Nat Genet"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0185","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/sj.gene.6363657","article-title":"Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies","volume":"1","author":"Koss","year":"2000","journal-title":"Genes Immun"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0190","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0161-5890(97)00052-7","article-title":"The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription","volume":"34","author":"Kroeger","year":"1997","journal-title":"Mol Immunol"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0195","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1006\/cyto.1999.0529","article-title":"Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor polymorphism","volume":"12","author":"Kroeger","year":"2000","journal-title":"Cytokine"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0200","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0016-5085(94)90696-3","article-title":"Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist","volume":"106","author":"Mansfield","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0205","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/371508a0","article-title":"Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria","volume":"371","author":"McGuire","year":"1994","journal-title":"Nature"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0210","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(00)02530-7","article-title":"Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial","volume":"356","author":"Mease","year":"2000","journal-title":"Lancet"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0215","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/infdis\/174.4.878","article-title":"Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease","volume":"174","author":"Nadel","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0220","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1086\/302932","article-title":"Localization of psoriasis-susceptibility locus psors1 to a 60-kb interval telomeric to hla-c","volume":"66","author":"Nair","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0225","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/clin.1994.1170","article-title":"Keratinocyte interleukin-10 expression is upregulated in tape-stripped skin, poison ivy dermatitis, and S\u00e9zary syndrome, but not in psoriatic plaques","volume":"73","author":"Nickoloff","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0230","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1365-2133.2001.04089.x","article-title":"Treatment of psoriatic arthritis with antitumour necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexate","volume":"144","author":"Ogilvie","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0235","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2362.1992.tb01480.x","article-title":"A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro","volume":"22","author":"Pociot","year":"1992","journal-title":"Eur J Clin Invest"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0240","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/08916939408995692","article-title":"Genetic susceptibility markers in Danish patients with type 1 (insulin-dependent) diabetes\u2014evidence for polygenicity in man. Danish Study Group of Diabetes in Childhood","volume":"19","author":"Pociot","year":"1994","journal-title":"Autoimmunity"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0245","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-3083.1995.tb03686.x","article-title":"Functional analysis of a new polymorphism in the human TNF alpha gene promoter","volume":"42","author":"Pociot","year":"1995","journal-title":"Scand J Immunol"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0250","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/BF02505046","article-title":"Adhesion molecules and IL-1 costimulate T lymphocytes in the autologous MECLR in psoriasis","volume":"288","author":"Prens","year":"1996","journal-title":"Arch Dermatol Res"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0255","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1074\/jbc.273.2.974","article-title":"Relative contribution of transcription and translation to the induction of tumor factor-alpha by lipopolysaccharide","volume":"273","author":"Raabe","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0260","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1523-1747.1999.00654.x","article-title":"Combined analysis of polymorphisms of the tumor necrosis factor-alpha and interleukin-10 promoter regions and polymorphic xenobiotic metabolizing enzymes in psoriasis","volume":"113","author":"Reich","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0265","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1523-1747.2001.01248.x","article-title":"Response of psoriasis to interleukin-10 is associated with suppression of cutaneous type 1 inflammation, downregulation of the epidermal interleukin-8\/CXCR2 pathway and normalization of keratinocyte maturation","volume":"116","author":"Reich","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0270","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-3083.1998.00300.x","article-title":"Presence of the IL-1RA allele 2 (IL-1RN*2) is associated with enhanced IL-1\u03b2 production in vitro","volume":"47","author":"Santilla","year":"1998","journal-title":"Scand J Immunol"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0275","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1046\/j.1365-2249.2001.01421.x","article-title":"Pathogenic function of IL-1 beta in psoriasiform skin lesions of flaky skin (fsn\/fsn) mice","volume":"123","author":"Schon","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0280","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1212\/WNL.52.3.595","article-title":"Association of interleukin-1\u03b2 and interleukin-1 receptor antagonist genes with disease severity in MS","volume":"52","author":"Schrijver","year":"1999","journal-title":"Neurology"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0285","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1080\/01621459.1986.10478341","article-title":"Modified sequentially rejective multiple test procedures","volume":"81","author":"Shaffer","year":"1986","journal-title":"J Am Stat Assoc"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0290","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/BF00217368","article-title":"Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat","volume":"91","author":"Tarlow","year":"1993","journal-title":"Hum Genet"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0295","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2133.1997.tb08779.x","article-title":"Association between interleukin-1 receptor antagonist (IL-1ra) gene polymorphism and early and late-onset psoriasis","volume":"136","author":"Tarlow","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0300","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/1523-1747.ep12371679","article-title":"The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response","volume":"101","author":"Uyemura","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0305","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1096-9896(199902)187:3<358::AID-PATH253>3.0.CO;2-8","article-title":"IL-1 beta and IFN-gamma induce the regenerative epidermal phenotype of psoriasis in the transwell skin organ culture system. IFN-gamma up-regulates the expression of keratin 17 and keratinocyte transglutaminase via endogenous IL-1 production","volume":"187","author":"Wei","year":"1999","journal-title":"J Pathol"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0310","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/hmg\/1.5.353","article-title":"Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product","volume":"1","author":"Wilson","year":"1992","journal-title":"Hum Mol Genet"},{"key":"10.1046\/j.0022-202x.2001.01642.x_bb0315","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1073\/pnas.94.7.3195","article-title":"Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation","volume":"94","author":"Wilson","year":"1997","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X1541543X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X1541543X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T19:34:14Z","timestamp":1704310454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X1541543X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["S0022202X1541543X"],"URL":"https:\/\/doi.org\/10.1046\/j.0022-202x.2001.01642.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}